Redmile Group, LLC Ayala Pharmaceuticals, Inc. Transaction History

Redmile Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.99 - $4.15 $107,613 - $451,109	-108,701 Reduced 24.17%	341,030 $372,000
Q1 2022 May 16, 2022	SELL	$3.5 - $9.11 $763,297 - $1.99 Million	-218,085 Reduced 32.66%	449,731 $1.79 Million
Q4 2020 Feb 16, 2021	BUY	$9.67 - $13.5 $11,120 - $15,525	1,150 Added 0.17%	667,816 $7.61 Million
Q2 2020 Aug 14, 2020	BUY	$10.0 - $15.92 $6.67 Million - $10.6 Million	666,666 New	666,666 $6.69 Million

Ticker AYLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,833,300
Description
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.